{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-26-125188","form_type":"8-K","ticker":"NXTC","cik":"0001661059","company_name":"NextCure, Inc.","filed_at":"2026-11-10T21:15:23+00:00","discovered_at":"2026-11-10T21:16:00.255788+00:00","generated_at":"2026-11-10T21:16:05.646319+00:00","sec_items":["2.02","9.01"],"event_type":"m_and_a","sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"NextCure Q3 net loss $6.8M; Avere merger financing grows to $820M, stockholder vote set for Dec 9","bullets":["Financing commitments supporting Avere merger rise to ~$820M: prior $320M concurrent private placement plus a new $500M placement; ~$266M satisfied by canceling Avere convertible notes.","Special stockholder meeting set for Dec 9, 2026 (record date Nov 3); S-4 declared effective Nov 6, 2026; combined company expected to trade on Nasdaq as AVRX.","Q3 net loss $6.8M vs $8.6M a year ago; R&D $4.5M (-$1.6M YoY), G&A $4.4M (+$1.6M on $1.8M of merger legal fees), restructuring net gain $2.0M.","Cash and marketable securities $8.7M at Sept 30, 2026, down $33.1M from $41.8M at Dec 31, 2025; $35.2M used in operations, offset by $1.2M ATM proceeds.","Delaware Chancery final order Nov 2, 2026 validated July 2025 reverse split; LNCB74 IND transferred to LigaChem Oct 6; legacy holders to receive CVRs."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-26-125188","json":"https://secwatch.observer/filing/0001104659-26-125188.json","markdown":"https://secwatch.observer/filing/0001104659-26-125188.md","text":"https://secwatch.observer/filing/0001104659-26-125188.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1661059/000110465926125188/0001104659-26-125188-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1661059/000110465926125188/nxtc-20261110x8k.htm"},"model":{"generated_by":"deepseek-v4.1-flash:cloud@v2","generated_at":"2026-11-10T21:16:05.646319+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}